Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/naloxone controlled-release tablets for chronic low back pain with opioid-induced constipation
2011-005061-20Phase 3Completed
- Sponsor
- Purdue Pharma
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxycodone + naloxone and oxycodone in chronic low back pain (CLBP) and opioid-induced constipation (OIC) (3 arms), sponsored by Purdue Pharma. Primary endpoint: Average pain over the last 24 hours. Started Mar 2012; status: completed.
02
Drugs
oxycodone + naloxoneoxycodone
03
Conditions
chronic low back pain (CLBP)opioid-induced constipation (OIC)
Beyond the preview
Go deeper on 2011-005061-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005061-20.